72 related articles for article (PubMed ID: 13168151)
1. [Treatment of Wilson's disease with 2,3-dimercaptopropanol].
MALECI O; CECOTTO C
Riv Neurol; 1953; 23(6):809-15. PubMed ID: 13168151
[No Abstract] [Full Text] [Related]
2. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
[No Abstract] [Full Text] [Related]
3. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
[No Abstract] [Full Text] [Related]
4. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
5. Wilson's disease.
Singh S; Behari M
J Assoc Physicians India; 2003 Feb; 51():183-90. PubMed ID: 12725264
[No Abstract] [Full Text] [Related]
6. [Wilson's disease].
Petrović M; Bogunović M; Jancić-Nedeljkov R; Cović M
Srp Arh Celok Lek; 1994; 122(5-6):184-5. PubMed ID: 17977425
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of Wilson's disease].
IWANOWSKI L
Neurol Neurochir Psychiatr Pol; 1954; 4(5):515-20. PubMed ID: 14356319
[No Abstract] [Full Text] [Related]
8. [Treatment of Wilson's disease].
Arima M
Horumon To Rinsho; 1971 Jan; 19(1):44-7. PubMed ID: 5101830
[No Abstract] [Full Text] [Related]
9. [Possibilities of treating Wilson's disease by stereotaxic thalamolysis].
Mingrino S; Pavan L
G Psichiatr Neuropatol; 1968; 96(3):487-93. PubMed ID: 4895955
[No Abstract] [Full Text] [Related]
10. [Wilson's disease revisited].
Vucelić B
Lijec Vjesn; 2000 Mar; 122(3-4):90-3. PubMed ID: 10932536
[No Abstract] [Full Text] [Related]
11. Wilson's disease presenting as depressive disorder.
Krishnakumar P; Riyaz A
Indian Pediatr; 2005 Nov; 42(11):1172-3. PubMed ID: 16340066
[No Abstract] [Full Text] [Related]
12. Wilson's disease presenting as status epilepticus.
Shukla R; Desai P; Vinod P
J Assoc Physicians India; 2006 Nov; 54():887-9. PubMed ID: 17249260
[TBL] [Abstract][Full Text] [Related]
13. The long term management of hepatolenticular degeneration (Wilson's disease).
SCHEINBERG IH; STERNLIEB I
Am J Med; 1960 Aug; 29():316-33. PubMed ID: 13747430
[No Abstract] [Full Text] [Related]
14. [Wilson's disease].
Schmidt HH
Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S208-10. PubMed ID: 16435711
[No Abstract] [Full Text] [Related]
15. Clinical improvement of a patient with severe Wilson's disease after a single session of therapeutic plasma exchange.
Hursitoglu M; Kara O; Cikrikcioglu MA; Celepkulu T; Aydin S; Tukek T
J Clin Apher; 2009; 24(1):25-7. PubMed ID: 19156772
[TBL] [Abstract][Full Text] [Related]
16. Persistence of elevated aminotransferases in Wilson's disease despite adequate therapy.
Iorio R; D'Ambrosi M; Marcellini M; Barbera C; Maggiore G; Zancan L; Giacchino R; Vajro P; Marazzi MG; Francavilla R; Michielutti F; Resti M; Frediani T; Pastore M; Vegnente A
Hepatology; 2004 Apr; 39(4):1173-4. PubMed ID: 15057922
[No Abstract] [Full Text] [Related]
17. Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
WARNOCK CG; NEILL DW
J Neurol Neurosurg Psychiatry; 1954 Feb; 17(1):70-4. PubMed ID: 13131080
[No Abstract] [Full Text] [Related]
18. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
19. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
20. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
